| (+)-Magnoflorine |
|
|
|
|
|
|
|
|
|
|
|
|
| Ethyl (E)-ferulate |
|
|
|
|
|
|
|
|
|
|
|
|
| (E/Z)-YLF-466D |
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-MRT199665 |
|
|
|
|
|
|
|
|
|
|
|
98.70% |
| (S)-β-Aminoisobutyric acid |
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| (±)-10-Gingerol |
|
|
|
|
|
|
|
|
|
|
|
|
| Phenformin |
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| 10-Gingerol |
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| 10-Hydroxy-2-decenoic acid |
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| 11β-HSD1-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
| Pinocembrin chalcone |
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| 10Z-Hymenialdisine |
|
|
|
|
|
|
|
|
|
|
|
|
| 2,6-Dimethoxy-1,4-benzoquinone |
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| Alisol A 24-acetate |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| 3α-Hydroxymogrol |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| 4-O-Methyl-ascochlorin |
|
|
|
|
|
|
|
|
|
|
|
|
| 4-PivO-NMT chloride |
|
|
|
|
|
|
|
|
|
|
|
|
| 5α-Androstane-3β,5,6β-triol |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| 7-Methoxyisoflavone |
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| 8-Prenylnaringenin |
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| 8-Chloroadenosine |
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| [6]-Gingerol |
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| A-769662 |
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| A17 |
|
|
|
|
|
|
|
|
|
|
|
99.4% |
| Acetic acid lead |
|
|
|
|
|
|
|
|
|
|
|
|
| AD1058 |
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| AdipoR agonist 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| AICA-riboside, 5′-phosphate |
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| Aldometanib |
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Alisol A |
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| ALKBH1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| ALKBH1-IN-3 prodrug |
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| Alloc-DOX |
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| AMARA peptide |
|
|
|
|
|
|
|
|
|
|
|
|
| AMARA peptide TFA |
|
|
|
|
|
|
|
|
|
|
|
98.53% |
| AMDE-1 |
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Amorphigenin |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 1 |
|
|
|
|
|
|
|
|
|
|
|
98.53% |
| AMPK activator 10 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 11 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 12 |
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| AMPK activator 13 |
|
|
|
|
|
|
|
|
|
|
|
98.78% |
| AMPK activator 14 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 15 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 16 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 17 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 18 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 19 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 2 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 2 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| AMPK activator 20 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 4 |
|
|
|
|
|
|
|
|
|
|
|
98.64% |
| AMPK activator 6 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 7 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 8 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator 9 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK activator C2 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK alpha 1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK α1β1γ1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
95.19% |
| AMPK-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| AMPK-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
97.16% |
| AMPK-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK-α1β1γ1 activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| AMPK/mTOR modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Ampkinone |
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| AMPKα1 activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Antidiabetic agent 7 |
|
|
|
|
|
|
|
|
|
|
|
|
| AR493 |
|
|
|
|
|
|
|
|
|
|
|
|
| ARUK2010489 |
|
|
|
|
|
|
|
|
|
|
|
96.64% |
| ARUK2010694 |
|
|
|
|
|
|
|
|
|
|
|
|
| ASP4132 |
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| ASS1 activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| ATP Synthesis-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Avicin D |
|
|
|
|
|
|
|
|
|
|
|
|
| BAY-3827 |
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| BC1618 |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Bempedoic acid |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Bempedoic acid-d4 |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Bempedoic acid-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| BI-9774 |
|
|
|
|
|
|
|
|
|
|
|
|
| Biguanide |
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| Biotin-AMPKα1β1γ1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| Biotin-AMPKα1β1γ2 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| Biotin-AMPKα1β2γ1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| Biotin-AMPKα2β1γ1 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| Biotin-Nuak2 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| BRSK1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
| Brsk2 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
| Butylate |
|
|
|
|
|
|
|
|
|
|
|
|
| CAD031 |
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| Calenduloside E |
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| Candidusin A |
|
|
|
|
|
|
|
|
|
|
|
|
| CB1R/AMPK modulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Chamaejasmine |
|
|
|
|
|
|
|
|
|
|
|
98.17% |
| Chitosan oligosaccharide |
|
|
|
|
|
|
|
|
|
|
|
91.0% |
| Cholesterol sulfate |
|
|
|
|
|
|
|
|
|
|
|
|
| Cholesterol sulfate-d7 sodium |
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Cholesteryl sulfate sodium |
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Cimiracemoside C |
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| COH-SR4 |
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Cryptolepine |
|
|
|
|
|
|
|
|
|
|
|
|
| CT-1 |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| D-Arabinose |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| D-Arabinose-13C |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinose-13C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-arabinose-13C-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinose-13C-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinose-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinose-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinose-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabitol |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| D-Arabitol-13C |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabitol-13C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabitol-13C-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| D-Arabinopyranose |
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| D-Arabinopyranose-13C5 |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| D942 |
|
|
|
|
|
|
|
|
|
|
|
|
| DBI-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Demethyleneberberine chloride |
|
|
|
|
|
|
|
|
|
|
|
98.90% |
| Dorsomorphin |
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| Dorsomorphin dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| Dorsomorphin dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Dox-btn2 |
|
|
|
|
|
|
|
|
|
|
|
98.80% |
| DX-8951 Hydroxy-acid |
|
|
|
|
|
|
|
|
|
|
|
|
| DX-8951 Hydroxy-acid sodium |
|
|
|
|
|
|
|
|
|
|
|
98.65% |
| EB-3D |
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| EGFR-IN-146 |
|
|
|
|
|
|
|
|
|
|
|
|
| Equisetin |
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Etilefrine |
|
|
|
|
|
|
|
|
|
|
|
97.03% |
| EX229 |
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| FAM-SAMS |
|
|
|
|
|
|
|
|
|
|
|
|
| FBPase-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
| Fenitrothion-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
| FGFR4-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
| Flindersine |
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Fluoxetine-Conjugated Platinum(IV) prodrug-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Foenumoside B |
|
|
|
|
|
|
|
|
|
|
|
|
| FSVVPSPK |
|
|
|
|
|
|
|
|
|
|
|
|
| FuBIG |
|
|
|
|
|
|
|
|
|
|
|
|
| FXR antagonist 4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Galbacin |
|
|
|
|
|
|
|
|
|
|
|
|
| Galegine hemisulfate |
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Galegine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Gamma-glutamylcysteine ammonium |
|
|
|
|
|
|
|
|
|
|
|
|
| Ginsenoside F2 |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| GL-V9 |
|
|
|
|
|
|
|
|
|
|
|
98.08% |
| Gomisin N |
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| GSK-690693 |
|
|
|
|
|
|
|
|
|
|
|
98.47% |
| GSK621 |
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| HDAC11-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| HK2-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
| HSF1/AMPK activator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| HTH-01-015 |
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| HTH-02-006 |
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| HUNK Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
| Hydroxycitric acid |
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| IHMT-MST1-39 |
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| IMM-H007 |
|
|
|
|
|
|
|
|
|
|
|
97.69% |
| IND 1316 |
|
|
|
|
|
|
|
|
|
|
|
|
| IQZ23 |
|
|
|
|
|
|
|
|
|
|
|
|
| Isovaleric acid |
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| JJO-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Kaempferol 3-O-sophoroside |
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Kaempferol-7-O-rhamnoside |
|
|
|
|
|
|
|
|
|
|
|
99.18% |
| Kanglexin |
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| KARI 101 |
|
|
|
|
|
|
|
|
|
|
|
|
| Kazinol A |
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| Kazinol U |
|
|
|
|
|
|
|
|
|
|
|
|
| KHKI-01128 |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| KMS99220 |
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| LCB-2122 |
|
|
|
|
|
|
|
|
|
|
|
|
| Leucic acid |
|
|
|
|
|
|
|
|
|
|
|
98.38% |
| Lipid-lowering agent-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Lixumistat |
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| Lixumistat acetate |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Lixumistat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.25% |
| LRRK2-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
| LRRK2/NUAK1/TYK2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| LW1564 |
|
|
|
|
|
|
|
|
|
|
|
|
| Malvidin-3-O-arabinoside chloride |
|
|
|
|
|
|
|
|
|
|
|
97.1% |
| MARK-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| MARK-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| MARK-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| MARK4 inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
98.29% |
| MARK4 inhibitor 2 |
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| Metformin (glycinate) |
|
|
|
|
|
|
|
|
|
|
|
|
| Metformin-13C2 (hydrochloride) |
|
|
|
|
|
|
|
|
|
|
|
|
| Methyl rosmarinate |
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| Mito-Esculetin |
|
|
|
|
|
|
|
|
|
|
|
|
| Mitochondrial complex I-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| MitoPBN |
|
|
|
|
|
|
|
|
|
|
|
95.00% |
| MK-3903 |
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| MK-3903 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
| MK8722 |
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Momordicine I |
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| Monascuspiloin |
|
|
|
|
|
|
|
|
|
|
|
95% |
| MOTS-c (human) |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| MOTS-c (mouse) |
|
|
|
|
|
|
|
|
|
|
|
99.23% |
| MOTS-c(human) acetate |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| MRT199665 |
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| MT 63-78 |
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| Multi-kinase-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
| Myricanol |
|
|
|
|
|
|
|
|
|
|
|
98.93% |
| Nandinine |
|
|
|
|
|
|
|
|
|
|
|
|
| Narazaciclib |
|
|
|
|
|
|
|
|
|
|
|
98.66% |
| Nepodin |
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| NEU-4438 |
|
|
|
|
|
|
|
|
|
|
|
|
| NFAT-133 |
|
|
|
|
|
|
|
|
|
|
|
|
| NMac1 |
|
|
|
|
|
|
|
|
|
|
|
|
| NPC26 |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| NuaK1(ARK5) Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| NUAK1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| NUAK1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| NUAK1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| Nuak2 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| O-304 |
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| OICR19451 |
|
|
|
|
|
|
|
|
|
|
|
|
| OSU-53 |
|
|
|
|
|
|
|
|
|
|
|
|
| OXPHOS-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| p-Synephrine |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| PDIC-DPC |
|
|
|
|
|
|
|
|
|
|
|
|
| Pegloxenatide |
|
|
|
|
|
|
|
|
|
|
|
90.00% |
| Petasin |
|
|
|
|
|
|
|
|
|
|
|
|
| PF-06409577 |
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| PF-06679142 |
|
|
|
|
|
|
|
|
|
|
|
|
| PF-06685249 |
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| PF-07293893 |
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| PF-739 |
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| PI3Kα-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
| Pinusolide |
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| PKC-iota inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| PPM-18 |
|
|
|
|
|
|
|
|
|
|
|
99.17% |
| Procyanidin C2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Propionyl-L-carnitine |
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| PT1 |
|
|
|
|
|
|
|
|
|
|
|
99.13% |
| Pterosin A |
|
|
|
|
|
|
|
|
|
|
|
94.07% |
| PXL770 |
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| QIK Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
|
|
|
|
|
|
| Relaxin H3 (human) |
|
|
|
|
|
|
|
|
|
|
|
|
| Relaxin H3 (human) TFA |
|
|
|
|
|
|
|
|
|
|
|
|
| Resolvin D3 |
|
|
|
|
|
|
|
|
|
|
|
|
| RMC-7977 |
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| RSVA405 |
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| SAMS |
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| SBI-0206965 |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Setmelanotide monoacetate |
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| SGC stimulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
| SIK-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
98.91% |
| SIK-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
| SIK-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| SMTIN-T140 |
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| STF-118804 |
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| STO-609 |
|
|
|
|
|
|
|
|
|
|
|
98.20% |
| STO-609 acetate |
|
|
|
|
|
|
|
|
|
|
|
|
| SU212 |
|
|
|
|
|
|
|
|
|
|
|
|
| Sweroside |
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Tanshinol borneol ester |
|
|
|
|
|
|
|
|
|
|
|
|
| Teneligliptin hydrobromide |
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Tezampanel etibutil |
|
|
|
|
|
|
|
|
|
|
|
|
| Thalidezine |
|
|
|
|
|
|
|
|
|
|
|
|
| THR-β agonist 9 |
|
|
|
|
|
|
|
|
|
|
|
|
| TMPA |
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| Tranexamic acid-13C6 |
|
|
|
|
|
|
|
|
|
|
|
|
| UCB9386 |
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| ULK1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| ULK1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
| Urolithin D |
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| VS-II-173 |
|
|
|
|
|
|
|
|
|
|
|
|
| WMJ-J-09 |
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| Wu-5 |
|
|
|
|
|
|
|
|
|
|
|
99.01% |
| WZ4003 |
|
|
|
|
|
|
|
|
|
|
|
98.22% |
| Xanthoangelol |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| XMD-17-51 |
|
|
|
|
|
|
|
|
|
|
|
|
| XMD-17-51 TFA |
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| XY221 |
|
|
|
|
|
|
|
|
|
|
|
|
| YLF-466D |
|
|
|
|
|
|
|
|
|
|
|
99.02% |
| YPLP |
|
|
|
|
|
|
|
|
|
|
|
|
| Ziptide |
|
|
|
|
|
|
|
|
|
|
|
|
| ZLN024 |
|
|
|
|
|
|
|
|
|
|
|
|
| ZLN024 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
98.51% |
| α-Terpineol |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| β-Patchoulene |
|
|
|
|
|
|
|
|
|
|
|
|
| Gamma-glutamylcysteine |
|
|
|
|
|
|
|
|
|
|
|
98.53% |
| Gamma-glutamylcysteine TFA |
|
|
|
|
|
|
|
|
|
|
|
96.68% |
| Buformin |
|
|
|
|
|
|
|
|
|
|
|
|
| Buformin-d9 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Syringaresinol |
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Gypenoside A |
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Trifolirhizin |
|
|
|
|
|
|
|
|
|
|
|
98.37% |
| Triadimefon |
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| Danthron |
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| Acetic acid |
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Acetic Acid-13C,d3-1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Acetic acid-d1 |
|
|
|
|
|
|
|
|
|
|
|
|
| Sodium acetate trihydrate, meets analytical specification of Ph. Eur. BP USP FCC E262, ≤0.00002% Al |
|
|
|
|
|
|
|
|
|
|
|
100.4% |
| Magnesium acetate tetrahydrate |
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| Metformin |
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Metformin-d6 |
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| Perfluorotetradecanoic acid |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Flavokawain C |
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Demethyleneberberine |
|
|
|
|
|
|
|
|
|
|
|
|
| Deoxyandrographolide |
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Deapi-platycodin D3 |
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| Pyraclostrobin-d6 |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Pyraclostrobin |
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Indoprofen |
|
|
|
|
|
|
|
|
|
|
|
99.36% |
| Kahweol |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Kirenol |
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Kazinol B |
|
|
|
|
|
|
|
|
|
|
|
|
| Urolithin B |
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Hawthorn Extract |
|
|
|
|
|
|
|
|
|
|
|
|
| Isomangiferin |
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| Gomisin J |
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Luteolin 7-diglucuronide |
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| Fenitrothion |
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Tipepidine citrate |
|
|
|
|
|
|
|
|
|
|
|
|
| Platycodin D |
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| Palmitelaidic acid |
|
|
|
|
|
|
|
|
|
|
|
99.4% |
| Palmitelaidic acid-d13 |
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Phaseoloidin |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Flurbiprofen axetil |
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| Flufenamic acid-13C6 |
|
|
|
|
|
|
|
|
|
|
|
99.5% |
| Flufenamic acid-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
| Flufenamic acid |
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Teneligliptin hydrobromide hydrate |
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Tranexamic acid |
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| 6-Azuridine |
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| (+)-Magnoflorine chloride |
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| Karanjin |
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Panduratin A |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Macranthoside B |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Vaccarin |
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Methyl succinate |
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Daphnetin |
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Glycycoumarin |
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Saponarin |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Buformin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Metformin-d6 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Metformin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Etilefrine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Phenformin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| Phenformin-d5 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
| Doxorubicin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Phellodendrine chloride |
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| (+)-Magnoflorine iodide |
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Clitorin |
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Miglitol |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Lithospermic acid |
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| Mogroside I E1 |
|
|
|
|
|
|
|
|
|
|
|
98.46% |
| Hydroxycitric acid tripotassium |
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Methyl cinnamate |
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Methyl cinnamate-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
| Cinnamyl Alcohol |
|
|
|
|
|
|
|
|
|
|
|
98.58% |
| Cinnamyl Alcohol-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
| Cinnamyl Alcohol-d9 |
|
|
|
|
|
|
|
|
|
|
|
|
| Rubrofusarin gentiobioside |
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| Atractyloside potassium salt |
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Amarogentin |
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Alizarin |
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| Poricoic acid A |
|
|
|
|
|
|
|
|
|
|
|
99.32% |
| Androsin |
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Jervine hydriodide |
|
|
|
|
|
|
|
|
|
|
|
|
| Dipentyl phthalate |
|
|
|
|
|
|
|
|
|
|
|
99.5% |
| Jujuboside B |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Chromium(III) acetate |
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Fortunellin |
|
|
|
|
|
|
|
|
|
|
|
98.31% |
| Ginkgolide C |
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| AICAR |
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| AICAR-13C2,15N |
|
|
|
|
|
|
|
|
|
|
|
|
| AICAR phosphate |
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Arjunolic acid |
|
|
|
|
|
|
|
|
|
|
|
98.17% |
| Marein |
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Xanthosine |
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Phellodendrine |
|
|
|
|
|
|
|
|
|
|
|
|
| Xanthosine dihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
| Sinigrin |
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Sinigrin hydrate |
|
|
|
|
|
|
|
|
|
|
|
99.92% |